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ABSTRACT
In order to enhance DNA triple helix stability
synthetic oligonucleotides have been developed
that bear amino groups on the sugar or base.
One of the most effective of these is bis-amino-U
(B), which possesses 5-propargylamino and
20-aminoethoxy modifications. Inclusion of this
modified nucleotide not only greatly enhances
triplex stability, but also increases the affinity for
related sequences. We have used a restriction
enzyme protection, selection and amplification
assay (REPSA) to isolate sequences that are bound
by the heavily modified 9-mer triplex-forming oligo-
nucleotide B6CBT. The isolated sequences contain
An tracts (n=6), suggesting that the 50-end of
this TFO was responsible for successful triplex
formation. DNase I footprinting with these
sequences confirmed triple helix formation at
these secondary targets and demonstrated no
interaction with similar oligonucleotides containing
T or 5-propargylamino-dU.
INTRODUCTION
Triple-stranded nucleic acids are generated by the
sequence-speciﬁc binding of oligonucleotides within the
duplex major groove (1–3). The third strand bases form
speciﬁc hydrogen bond contacts with the Hoogsteen face
of the duplex purines and these structures are therefore
usually restricted to oligopurine.oligopyrimidine tracts.
The third strand can bind either parallel or antiparallel
to the duplex purine strand, depending on its sequence.
CT-containing oligonucleotides bind in a parallel arrange-
ment, generating C
+.GC and T.AT triplets (4,5), while
GT- or GA-containing third strands bind antiparallel
forming A.AT, G.GC and T.AT triplets (6). Although
the parallel motif requires conditions of low pH, necessary
for protonation of the third strand cytosine, this has been
more widely studied than the antiparallel form as
purine-rich oligonucleotides can form other competing
structures.
Although triplex formation occurs with high speciﬁcity,
these complexes are usually less stable than their duplex
counterparts, largely due to electrostatic repulsion
between the three negatively charged strands. A number
of strategies have been employed to enhance the binding,
including attachment of other DNA binding groups, such
as intercalators (7–10), addition of exogenous triplex-
binding ligands (11–15) or inclusion of modiﬁed nucleo-
tides that bear charged groups on either the sugar (16,17)
or the base (18–22). The most successful of these nucleo-
tide analogues is bis-amino-U (B), Figure 1A, which
contains a propargylamino group attached to the
5-position of the base and a 20-aminoethoxy group
attached to the sugar (23–27). This analogue combines
the two modiﬁcations, which had previously been inde-
pendently shown to enhance triplex formation. The
propargylamino group is thought to interact with the
adjacent 50-phosphate on the third strand, while
the aminoethoxy group interacts with a phosphate in
the duplex purine strand (19). Inclusion of a single B
residue within an 18-mer triplex-forming oligonucleotide
(TFO) increased the melting temperature by 8 C at pH 6.0
(25) and facilitated triplex formation at higher pH values
(28). Studies on the speciﬁcity of TFOs containing one B
residue showed that the B.GC triplet is weaker than B.AT
(11 C lower melting temperature), but the interaction with
TA and CG was no stronger than the mismatched triplets
formed with T (25). B therefore has enhanced discrimin-
ation against pyrimidines, but has the same selectivity
between A and G as the natural base T. These previous
studies on speciﬁcity used TFOs that only contain one B
residue; we were concerned to examine the speciﬁcity of
TFOs that contain multiple B-residues, since these may
possess a net positive charge and might therefore show
reduced selectivity, interacting with secondary sites.
One method for identifying the preferred sites of
DNA-binding ligands is Restriction Endonuclease
Protection, Selection and Ampliﬁcation (REPSA), which
was ﬁrst described by Hardenbol and van Dyke (29–33).
*To whom correspondence should be addressed. Tel: +44 23 8059 4374; Fax: +44 23 8059 5159; Email: k.r.fox@soton.ac.uk
Published online 17 December 2011 Nucleic Acids Research, 2012, Vol. 40, No. 8 3753–3762
doi:10.1093/nar/gkr1119
 The Author(s) 2011. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This technique has previously been used to study the inter-
action of proteins, small molecules and oligonucleotides
with DNA. Since it does not require the physical separ-
ation of the bound and unbound templates, it is ideal for
studying non-covalent interactions. Like SELEX, REPSA
uses a population of synthetic DNA templates, which
contains a central region of randomized bases that are
challenged by the ligand. A recognition site for a type
IIS restriction enzyme, such as Fok I (GGATG), is
included in the template adjacent to this random region.
Since type IIS restriction enzymes cut at a ﬁxed distance
from their binding site they can be used to cleave a region
with an unknown sequence. This makes REPSA superior
to other similar methods as no prior knowledge of the
target sequence is required. When these random duplex
targets are incubated with the ligand, a small number
will contain the correct binding sites and will be protected
from enzyme cleavage. The majority of the templates will
not be bound by the ligand and so will be cleaved. The
reaction mixture is then subjected to polymerase chain
reaction (PCR), in which only the bound (uncleaved) tem-
plates will undergo exponential ampliﬁcation. Each round
of selection therefore enriches the oligonucleotide pool for
templates that contain the ligand-binding site and after
several rounds of selection the remaining templates are
cloned and sequenced.
This study examines the binding of a short 9-mer triplex
forming oligonucleotide, which contains 7-bis-amino-U
residues. We ﬁrst examine its interaction with a
fragment that contains its predicted binding site,
and then use REPSA to isolate other sequences to
which it binds. The interaction with these secondary
binding sites is then conﬁrmed by DNase I footprinting
and compared with oligonucleotides that contain T or
propargylamino-dU.
MATERIALS AND METHODS
Oligonucleotides
All oligonucleotides were synthesized on an Applied
Biosystems ABI 394 automated DNA/RNA synthesizer
on the 0.2- or 1-mmol scale using the standard cycles of
acid-catalysed detritylation, coupling, capping and iodine
oxidation procedures. Phosphoramidite monomers and
reagents were purchased from Applied Biosystems or
Link Technologies. The phosphoramidites for B and
propargylamino-U (P) were prepared as previously
described.(19,27) The 9-mer triplex-forming oligonucleo-
tide used in the REPSA experiments had the sequence
50-BBBBBBCBT, while 50-TTTTTTCTT and
50-PPPPPPCPT were also used in the footprinting experi-
ments. The naphthylquinoline triplex-binding ligand was
provided by Dr L. Strekowski, Dept. Chemistry, Georgia
State University, Atlanta.
REPSA. REPSA was performed as previously described
(29). The selection template used for these experiments
had the sequence 50-GTAGGATCCTGACTGGATG
Figure 1. (A) Chemical structures of bis-amino-U and propargylamino-dU. (B) DNase I footprint showing the interaction of B-TFO with the
tyrT(43-59) fragment. The experiment was performed in 50mM sodium acetate pH 5.0; TFO concentrations (mM) are shown at the top of each gel
lane. The DNA was labelled at the 30-end; the gel therefore runs 50–30 from top to bottom. The lane labelled control shows digestion of the DNA in
the absence of oligonucleotide; GA is a marker speciﬁc for purines. The exact target site is shown by the ﬁlled box and the accompanying
enhancement is indicated by an asterisks. Secondary binding sites are shown by the unﬁlled boxes and the enhancements are indicated by bracketed
asterisks. (C) Sequence of the oligopurine tract in tyrT(43–59) and its interaction with the modiﬁed TFOs. The exact target site is boxed.
(D) Sequence of a part of the tyrT(43–59) fragment showing the position of the secondary binding sites, which are underlined and the enhancements,
which are shown in bold. The exact target site is boxed.
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bases show the FokI recognition sequence). Double-
stranded DNA was generated from this by annealing the
primer 50-CTGAAGCTTGTCAGGAAGA-30, which had
been labelled with
32P at the 50-end, and extending with
Taq polymerase. The double-stranded template containing
the 15-bp random sequence was then puriﬁed on a 6%
non-denaturing polyacrylamide gel and resuspended in
10ml Fok I buffer (50mM potassium acetate, 20mM
Tris-acetate pH 7.9, 10mM magnesium acetate, 1mM
dithiothreitol). Ten microlitres of 10-mM oligonucleotide
50-BBBBBBCBT, dissolved in 50mM sodium acetate pH
5.0, was then added and the mixture was equilibrated for
1h at 20 C (the ﬁnal pH was about 5.6). The complex was
then cleaved with 8U FokI for 5min at 37 C and the
products of the reaction were subjected to PCR.
Unbound sequences were cleaved by the enzyme and
were not ampliﬁed by PCR while those protected by the
triplex-forming oligonucleotide were selectively ampliﬁed.
By including the FokI recognition sequence (GGATG) in
the primer sequence, we avoided the selection of any
nuclease-resistant products that arise from mutations in
the restriction enzyme recognition site. PCR ampliﬁcation
was performed by mixing 10ml of the cleavage reaction
with 15ml of the labelled forward primer 50-CTGAAGC
TTGTCAGGAAGA, 2ml of unlabelled 50-GTAGGATC
CTGACTGGATG (80mM), 1ml 25mM dNTPs, 5ml
10xTaq buffer and 5U of Taq polymerase in a total
volume of 50ml. The mixture was subject to 15 cycles of
93 C (30s) and 50 C (3min). A further two cycles of PCR
were then performed after adding 1ml dNTPs, 2.5ml un-
labelled forward primer and 5U of Taq polymerase. This
pulse-chase procedure, using a low concentration of the
radiolabelled primer for the initial cycles, ensures efﬁcient
incorporation of the radiolabel, while preventing the for-
mation of any mismatched duplexes, which would have
arisen from the annealing of PCR products. The ampliﬁed
DNA was run on an 8% non-denaturing polyacrylamide
gel from which the full-length products were puriﬁed. The
puriﬁed template, enriched in binding sites for the TFO,
was redissolved in 10ml of FokI buffer and subjected to a
further round of REPSA selection. The procedure was
repeated 10 times. After the tenth round of selection, the
products were cleaved with BamHI and HindIII and
ligated into pUC19 that had also been cleaved with
BamHI and HindIII. The ligated plasmid was transformed
into Escherichia coli TG2 and plated on agar plates con-
taining 0.02% X-gal, 1mM IPTG and 100mg/ml carbeni-
cillin. White colonies were picked from these plates and
sequenced. Colonies were ﬁrst sequenced manually using a
T7 sequencing kit (USB), although the sequences of all the
fragments used for the footprinting experiments were sub-
sequently conﬁrmed by Euroﬁns MWG Operon,
Ebersberg, Germany.
DNA fragments for footprinting. Plasmids containing the
REPSA templates were cleaved with EcoRI and labelled
at the 30-end with a-
32P[dATP] using reverse transcriptase.
The fragment of interest was then released by cutting with
HindIII, puriﬁed on a 6% polyacrylamide gel and
redissolved in 10mM Tris–HCl pH 7.5, containing
0.1mM EDTA at a concentration of at least 10c.p.s per
microlitre (as determined using a hand-held Geiger
counter). The tyrT(43-59) restriction fragment, which
contains an 18-bp oligopurine tract that includes the
target site for these 9-mer TFOs, was prepared as previ-
ously described (34).
DNase I footprinting. DNase I footprinting was per-
formed as previously described (35). Brieﬂy, 1.5mlo f
radiolabelled DNA was mixed with 3ml of oligonucleotide
dissolved in 50mM sodium acetate pH 5.0 to give a ﬁnal
concentration of between 0.03 and 1mM and incubated
overnight at 20 C. The mixture was cleaved by adding
2ml DNase I (typically 0.01U/ml) dissolved in 20mM
NaCl, 2mM MgCl2 and 2mM MnCl2, stopping the
reaction after 2min with 4.5ml formamide containing
10mM EDTA and bromphenol blue. The products of
the reaction were separated on a 9% denaturing polyacryl-
amide gel containing 8M urea. After electrophoresis the
gels were ﬁxed, dried and subjected to autoradiography
using a phosphorimager screen (Kodak), which was
scanned with a Storm phosphorimager.
RESULTS
The 18-bp oligopurine tract in tyrT(43–59) has often been
used to examine the binding of modiﬁed triplex-forming
oligonucleotides (19,24,25,36,37). Single base mutations
within this target have been used to examine the binding
selectivity of oligonucleotides that contain one or more
bis-amino-U (B) residues (25). These studies have shown
that B has a very high afﬁnity for AT relative to all other
Watson–Crick base pairs in DNA and that each B.AT
triplet increases the melting temperature by about 8 C
relative to T.AT. Binding to GC is much weaker and
B-modiﬁed oligonucleotides show enhanced discrimin-
ation against YR compared with T. However, we were
concerned that oligonucleotides that contain multiple B
substitutions, generating TFOs with a net positive
charge, might show reduced selectivity and interact with
other secondary sites. We therefore examined the inter-
action of the 9-mer TFO 50-BBBBBBCBT, which is
expected to have a formal charge of +5 at physiological
pH, with its target site in tyrT(43-59) (Figure 1C) by
DNase I footprinting and the results are shown in
Figure 1B. As expected, a clear footprint is produced at
the intended target (indicated by the ﬁlled box), which
persists to nanomolar concentrations. As previously
noted, this footprint is accompanied by enhanced DNase
I cleavage at the 30-(lower) end of the target site
(19,24,36,38). In addition to this footprint, other regions
of protection are evident at the highest TFO concentration
(1mM) as indicated by the open boxes, and the primary
footprint is much larger, extending throughout the entire
oligopurine tract. Enhanced cleavage is also observed at
the 30-ends of each of these secondary sites. The location
of these secondary sites is shown in Figure 1D. No sec-
ondary binding was observed with the unmodiﬁed TFO
50-TTTTTTCTT or the propargylamino-U-modiﬁed
50-PPPPPPCPT (data not shown). Visual inspection of
these secondary sites does not reveal any obvious
Nucleic Acids Research,2012, Vol.40, No. 8 3755common sequence characteristics. REPSA experiments
were therefore carried out to select the preferred binding
sites for this oligonucleotide from a pool of random
templates.
Since the conditions of the REPSA experiments are
limited by the pH requirement of the selecting type IIS
restriction enzyme (FokI) we ﬁrst examined the pH de-
pendence of these secondary sites (data not shown).
Although the primary footprint was still evident at
pH 7.0, the secondary sites had largely disappeared at
pH 6.0 and above (Supplementary Figure S1). These sec-
ondary sites also disappeared within 1min when the pH
was rapidly raised from pH from 5.0 to 6.0 or 7.0. A low
pH was therefore employed in these experiments in order
to observe the secondary sites, although we observed that
FokI cleavage was at least 100-fold slower at pH 5.0 and
6.5 than at pH 7.9.
REPSA
REPSA selection was performed with FokI using the
random template in the presence of 5mM B-substituted
TFO. This TFO concentration is higher than might
normally be employed in gene inhibition studies, but was
used in order to exaggerate the proportion of secondary
binding sites. Out of 77 colonies picked for sequencing,
45 contained an insert that could not be fully sequenced
(possibly because they adopt unusual structures). The
other 32 colonies were sequenced and the sequences of
the N15 random regions are shown in Supplementary
Table S1. As the aim of this work was to compare the
secondary binding sites with the exact target sequence,
we only examined templates that showed some similarity
to the exact target. Fourteen of these sequences, each of
which contained an oligo(dA) tract, were therefore chosen
for footprinting (Table 1). Sequence 6 is included as it was
originally thought to have a run of six As but was
re-sequenced when the B-TFO failed to produce a foot-
print and was found to contain a pyrimidine interruption.
We considered that the other sequences were less likely to
bind the TFO and are likely to be random sequences,
which were not screened out by REPSA or which were
refractory to FokI cleavage for other reasons. Such se-
quences might have been eliminated with further rounds
of REPSA, but we were concerned to avoid introducing
mutations in the template sequences. Indeed, it can be seen
that some of the sequences are not the same length as the
original random template; this is an acknowledged limita-
tion of the REPSA technique. The relatively high level of
unselected sequences may also arise because FokI is not
producing efﬁcient double-strand cleavage under these
conditions, allowing the persistence of some unbound
templates.
An interesting pattern is evident in these oligo(dA)-con-
taining sequences; the selected templates were all in the
same orientation, with the purine-rich strand opposite
to the GGATG of the FokI site (i.e. on the same strand
as CATCC). As a consequence, all the footprinting experi-
ments described below display the purine-rich strand of
the target. None of the isolated fragments were in the
opposite orientation with oligo(T) on the GGATG
-containing strand. This is presumably a property of the
selecting enzyme FokI and will be considered further in
the ‘Discussion’ section.
DNase I footprinting
Radiolabelled DNA fragments containing 14 of the
REPSA-selected sequences were prepared and subjected
to DNase I footprinting in the presence of varying con-
centrations of 50-BBBBBBCBT (B-TFO), 50-PPPPPPCPT
(P-TFO) or 50-TTTTTTCTT (T-TFO). In each case, the
radiolabelled DNA fragment and the TFO were incubated
overnight at 20 C in 50mM sodium acetate pH 5.0. The
results for the B-substituted TFO are shown in Figures 2
and 3. Since no footprints were observed with the
P-substituted TFO at concentrations up to 30mM, these
experiments were repeated in the presence of 10mM
naphthylquinoline triplex-binding ligand and these
results are presented in Figure 4. No footprints were
evident with the unmodiﬁed T-TFO on any of these se-
quences at concentrations up to 30mM, even in the
presence of the triplex-binding ligand (data not shown).
The results for the various targets will be described in
turn, while the positions of the various footprints are
summarized in Table 2. The addition of 5mM MgCl2 gen-
erally made no difference to the position of the footprints,
merely enhancing the strength of interaction with the
P-TFO. In a few instances, this produced slightly different
cleavage patterns with P-TFO in the presence of the
triplex ligand and these are presented in Supplementary
Figure S2.
Sequence 1. This sequence contains the closest match to
the perfect target site with a single G-to-C mutation, and
contains a run of seven contiguous As followed by CAA.
DNase I cleavage patterns show that the B-TFO produces
Table 1. Sequences of the central regions of
clones obtained from REPSA selection, corres-
ponding to the N15 region in the random
template
Number Sequence
1 CAATCAAAAAAACAA
2 AAAAAAAAGTTGCTCT
3 CCCCGAACAAAAAAA
4 CAAAAAAAGAGAGAC
5 TATTGCTAAAAAAGG
6 AAATAAACGGCCATTG
7 CCAGAGCACAAAAAACAA
8 GGTAAAAAACCGGCA
9 CAACTCAAAAAATCA
10 CCCTAAAAATAACAA
11 GCAGTAAAAAAACTA
12 AAGAAAAGCAATGGGATCT
13 CACACGCAAAAAAG
14 AAGAAAAAACAGCTCCTAC
For sequences 2, 4, 12 and 14 the ﬁrst two As
correspond to the bases in the ﬂanking sequence.
The strand shown is the one that is labelled on the
footprinting gels and is the complementary strand
to the original template strand. The oligo(dA)
tracts are given in bold.
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even though this fragment does not contain its correct
binding site, conﬁrming that REPSA had successfully
selected a TFO-binding site. Unusually, compared to
many of the sequences described below, no enhanced
cleavage is evident at the 30-(lower) triplex–duplex
junction. This fragment contains a run of seven consecu-
tive As and the lower end of this footprint is coincident
with the 30-end of this tract. The upper end of the foot-
print extends beyond the A-tract by 2–3 bases, as shown in
Table 2. Triple helix protection from DNase I cleavage
does not arise from direct steric blockage, as the enzyme
Figure 2. DNase I footprints showing the interaction of B-TFO with REPSA-selected sequences 1–7. The experiments were performed in 50mM
sodium acetate pH 5.0; TFO concentrations (mM) are shown at the top of each gel lane. The DNA was labelled at the 30-end; the gel therefore runs
50–30 from top to bottom. The lanes labelled ‘control’ show digestion of the DNA in the absence of oligonucleotide; tracks labelled ‘GA’ are markers
speciﬁc for purines. The locations of the footprints are indicated by the ﬁlled boxes and any accompanying enhancements are indicated by asterisks.
Figure 3. DNase I footprints showing the interaction of B-TFO with REPSA-selected sequences 8–14. The experiments were performed in 50mM
sodium acetate pH 5.0; TFO concentrations (mM) are shown at the top of each gel lane. The DNA was labelled at the 30-end; the gel therefore runs
50–30 from top to bottom. The lanes labelled ‘control’ show digestion of the DNA in the absence of oligonucleotide; tracks labelled ‘GA’ are markers
speciﬁc for purines. The locations of the footprints are indicated by the ﬁlled boxes and any accompanying enhancements are indicated by asterisks.
Nucleic Acids Research,2012, Vol.40, No. 8 3757and third strand are located in different grooves. A typical
triplex footprint extends for 3–4 bases above (50-) the
target site, while the lower (30) end of the footprint
matches the end of the triplex, and is often
accompanied by enhanced cleavage of the terminal
base at the triplex–duplex junction (19,24,36,38). Based
on these observations, it seems reasonable to suggest
that the B-TFO is bound to the A7 tract and this will
be considered further in the ‘Discussion’ section. In
contrast, no footprints were observed with the T- or
P-TFOs at concentrations up to 30mM, although
addition of 10mM of the naphthylquinoline
triplex-binding ligand induces a clear footprint in the
same region with the P-TFO, which persists to a con-
centration of about 3mM (Figure 4). This interaction is
further enhanced by the addition of magnesium chloride
(5mM); in these conditions, the footprint persists to
about 0.3mM and is accompanied by enhanced
cleavage at the terminal A in the sequence CAA
(Supplementary Figure S2).
Figure 4. DNase I footprints showing the interaction of P-TFO with REPSA-selected sequences 1–14 in the presence of 10mM naphthylquinoline
triplex-binding ligand. The experiments were performed in 50mM sodium acetate pH 5.0; P-TFO concentrations (mM) are shown at the top of each
gel lane. The lanes labelled ‘control’ show digestion of the DNA in the absence of oligonucleotide; tracks labelled ‘GA’ are markers speciﬁc for
purines. The locations of the footprints are indicated by the ﬁlled boxes and any accompanying enhancements are indicated by asterisks.
3758 Nucleic Acids Research, 2012,Vol.40, No. 8Sequence 2. This sequence contains nine contiguous As
followed by a G. The B-substituted TFO produces a foot-
print at the highest concentration (1mM), which is
accompanied by two enhancements at the 30-end of the
oligopurine tract. A similar footprint can be seen with
the P-TFO in the presence of the triplex ligand (at a
TFO concentration of 30mM), although the two enhance-
ments are shifted one base further down compared with
the B-TFO. The presence of two enhanced bands may
indicate that the TFO can be bound in more than one
location, each of which produces enhanced cleavage at
its 30-end.
Sequence 3. This sequence contains seven contiguous As
followed by three pyrimidines (TTC). The B-TFO
produces a footprint at the highest concentration (1mM),
although one band is still evident within this region
(Figure 2). This protection is accompanied by three
enhanced bands at the lower (30) end of this region,
which may again suggest multiple binding locations on
this target. The P-TFO does not produce a footprint
with this sequence, although addition of the triplex
ligand produces a footprint in a similar location at the
highest concentration (30mM). Three enhanced cleavage
products are again evident at the 30-end of this footprint,
although their relative intensities are different to those
seen with the B-TFO alone.
Sequence 4. This sequence contains seven contiguous As
followed by three purines (GAG). The B-TFO produces a
clear footprint on this template at a concentration of 1mM
(Figure 2), which is accompanied by a single enhancement
at the guanine at the 30-end of the A-tract. An unusual
feature is that three bands below this enhancement also
show attenuated cleavage. The B- and T-TFOs did not
produce footprints on this sequence, although the addition
of the triplex ligand generated a footprint with 10mM
P-TFO. This ligand-induced footprint is accompanied
by several enhanced bands and is one base shorter at the
30-end than with the B-TFO.
Sequence 5. This sequence contains six contiguous As
followed by GGT. The B-TFO produces a clear footprint
on this template at a concentration of 1mM (Figure 2),
which is accompanied by two enhanced cleavage products
at the 30-(lower) end of the footprint corresponding to the
terminal A and the following G. The P-TFO does not
produce a footprint on this template, even at a concentra-
tion of 30mM, although the addition of 10mM triplex
ligand produces a clear footprint, which persists to
about 3mM, and is very similar to that produced by the
B-TFO alone. Further addition of 5mM MgCl2 causes the
footprint to extend one base further in the 30-(lower) dir-
ection, with enhancement in the two guanines
(Supplementary Figure S2).
Sequence 6. This sequence contains an interrupted A-tract
(AAATAAAC). None of the TFOs altered the DNase I
cleavage pattern of this template under any conditions
(Figures 2 and 4).
Sequence 7. This sequence is similar to sequence 1, but the
A-tract is one base shorter (A6CAA). Once again the
B-TFO produces a footprint within the REPSA-selected
region, which is evident at the highest TFO concentration
(1mM). This is accompanied by a faint enhancement at the
terminal A. No footprints were produced with the T- and
P-TFOs alone, although the addition of 10mM triplex
ligand produced a clear footprint with 10mM P-TFO,
with no evident enhanced cleavage (as noted with
sequence 1).
Sequence 8. This sequence contains six contiguous As
followed by CCG. The B-TFO produces a DNase I foot-
print at the highest concentration (1mM) (Figure 3) which
is accompanied by enhanced cleavage at the terminal A of
the A6-tract. The T- and P-TFO did not produce foot-
prints, although in the presence of 10mM triplex ligand
30mM P-TFO generated a similar footprint to that
produced by B-TFO alone.
Sequence 9. This sequence contains six contiguous
As followed by TCA. The B-TFO produces attenuated
DNase I cleavage within this A-tract, which is
accompanied by four enhancements at the 30-end
(Figure 3). The T- and P-TFOs do not affect the
cleavage pattern at concentrations as high as 30mM, but
a clear footprint is produced with 30mM P-TFO in the
presence of 10mM triplex ligand, which is also
accompanied by several enhancements.
Sequence 10. This sequence contains only ﬁve contiguous
As followed by TAA. The B-TFO again produces a foot-
print with this target at a concentration of 1mM, which is
accompanied by three bands of enhanced cleavage at the
30-end. In this case, no footprints are produced by the T-
or P-TFOs even in the presence of 10mM triplex ligand,
although further addition of 5mM MgCl2 to the P-TFO
plus triplex ligand produces a footprint that is similar to
that seen with B-TFO alone (Supplementary Figure S2).
Table 2. Locations of the footprints and enhancements observed with
the REPSA footprinting fragments
Number Sequence
1 AGGAAGACAATCAAAAAAACAATTCATCC
2 AGGAAGAAAAAAAAGTTGCTCTTTCATCC
3 AGGAAGACCCCGAACAAAAAAATTCATCC
4 AGGAAGACAAAAAAAGAGAGACTTCATCC
5 AGGAAGATATTGCTAAAAAAGGTTCATCC
7 AGGAAGACCAGAGCACAAAAAACAACCCTCATCC
8 AGGAAGAGGTAAAAAACCGGCATTCATCC
9 AGGAAGACAACTCAAAAAATCATTCATCC
10 AGGAAGACCCTAAAAATAACAATTCATCC
11 AGGAAGAGCAGTAAAAAAACTATTCATCC
12 AGGAAGAAAAGCAATGGGATCTTTCATCC
13 AGGAAGACACACGCAAAAAAGTTCATCC
14 AGGAAGAAAAAACAGCTCCTACTTCATCC
The selected sequences are shown in large type, while the adjacent
ﬂanking regions in the template are shown in smaller type and italics.
Bases shown in bold correspond to positions of enhanced cleavage,
while the footprints are underlined.
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followed by CTA. The B-substituted TFO produces a
footprint at a concentration of 0.3mM with two
enhanced bands at the 30-end of the A-tract. No footprints
were produced with T- and P-TFO alone. The addition of
10mM triplex ligand produces a footprint with P-TFO at a
concentration of 3mM in the same position as seen with
B-TFO alone. This is accompanied by enhanced cleavage
though the precise pattern of these enhancements is not
the same as that with B-TFO.
Sequence 12. In this sequence the oligo-A tract is inter-
rupted by a single guanine and so the longest A-tract
contains only four contiguous As. The B-TFO attenuates
DNase I cleavage within this purine tract at a concentra-
tion of 1mM and produces a single enhanced cleavage
product at a G at its 30-end. The P- and T-TFOs did not
affect the DNase I cleavage pattern, even in the presence
of the triplex ligand.
Sequence 13. This sequence contains six contiguous As
followed by GTT. The B-TFO produces a footprint on
this template at a concentration of 1mM, which is
accompanied by two bands of enhanced cleavage that
are coincident with the terminal AG. In the presence of
10mM triplex ligand the P-TFO produces a similar foot-
print that persists to a concentration of 3mM. The same
two enhancements as seen with the B-TFO are also
evident.
Sequence 14. This sequence contains six contiguous As
followed by CAG. The B-TFO produces a clear footprint
within this oligopurine tract, although no enhanced
cleavage products are evident. A similar pattern is
evident with P-TFO in the presence of 10mM triplex
ligand.
DISCUSSION
The results presented in this paper clearly show that this
heavily modiﬁed B-substituted TFO can bind to second-
ary sites. The interaction is not non-selective, but high
afﬁnity binding is observed at DNA sites that contain
triplex mismatches and several of the REPSA-selected
targets bind the B-TFO at sub-micromolar concentra-
tions, even though they do not contain the exact target
site. This is particularly striking in view of the short length
of the TFO, which is only a 9-mer. This interaction
appears to be restricted to the bis-amino-U modiﬁcation
since T- or P-containing TFOs showed no interaction with
these target sites at concentrations up to 30mM (although
some sequences showed interaction with P-TFO in the
presence of the triplex-binding ligand).
The exact location of the TFO cannot be accurately
deduced from these footprints as DNase I cleavage is gen-
erally poor within these oligopurine tracts. However,
most, though not all, of the selected sequences contain
an A-tract that is 6bp long. We assume that this corres-
ponds to interaction with the six consecutive B-residues in
the TFO. Sequence 6, for which the longest A-tract is only
3bp, shows no evidence of triplex formation. The two A3
tracts in this sequence, which are separated by a single T,
are clearly not sufﬁcient to generate a secondary binding
site. Sequence 12 only contains an A4 tract, although this
is preceded by AAG and one of the bis-amino-U residues
in the B6-tract must be interacting with this GC base pair.
This seems reasonable since our previous work has shown
that B can bind to an isolated GC interruption (about
15-fold weaker than to AT, but much stronger than to
TA or CG) (25). The position of the enhancement with
this sequence suggests that the 30-G is the terminal base of
this triplex, forming a standard C
+.GC triplet. Sequence
10 also contains a shorter A-tract (A5), although this is
followed by TAA. The enhancements seen with this foot-
print suggest that the TFO can bind in more than one
location, although the strongest enhancement is at the
ﬁrst A following the TA interruption. In contrast,
sequence 9 also possesses an A6 tract, yet produced one
of the weakest footprints.
These results suggest that the binding of this TFO is
dominated by the run of six consecutive bis-amino-U
residues. The last three bases at the 30-end of the TFO
(CBT) seem to be less important for sequence recognition.
This is emphasized by the observation that several of the
selected A-tracts are ﬂanked by a 30-G, at which there is
enhanced DNase I cleavage (sequences 2, 4, 5, 12 and 13),
suggesting that even the C is not involved in the secondary
triplex binding site. The lower stringency at the 30-end of
the TFO contrasts with earlier work that employed
REPSA to examine the selectivity of a 19-mer
GT-oligonucleotide, for which the 13 bases at the 30-end
of the TFO were shown to be sufﬁcient for binding (30).
However, this previous study concerned antiparallel
triplexes, and so also involved the 50-end of the target
site. It also employed natural nucleotides with a lower
afﬁnity, whereas in the present study the 50-end of the
TFO is more heavily modiﬁed than the 30-end to achieve
high-afﬁnity interactions.
Previous work with bis-amino-U studied its interaction
with single base mismatches and showed that, as well as
forming strong complexes with AT, it also formed a
weaker triplet with GC, but showed enhanced discrimin-
ation against CG and TA, compared with the unmodi-
ﬁed nucleotide T (25). It is therefore not surprising
that these secondary sites are all based on A-tracts;
other mismatched triplet combinations do not appear
to beneﬁt from addition of the 20-aminoethoxy or
5-propargylamino-dU substitutions. The speciﬁc beneﬁts
of these additions are also evident from the observation
that B-containing TFOs do not stabilize the triplexes
formed with parallel or antiparallel GT-containing oligo-
nucleotides. It should be noted that non-speciﬁc binding
of triplex-forming oligonucleotides can also occur by
looping out regions of the TFO (39). This is unlikely
with this short 9-mer oligonucleotide, but we cannot
exclude the possibility that one or more of the third
strand nucleotides is looped out from the duplex.
This study successfully isolated a number of clones,
which clearly represent secondary binding sites for this
TFO. However, none of these sequences represents the
exact target site (A6GAA), although sequence 1 is only
one base different (changing a G to C). At ﬁrst sight this
3760 Nucleic Acids Research, 2012,Vol.40, No. 8is surprising, although it is likely to be the result of the
TFO concentration (5mM) used in these experiments,
which is much higher than the afﬁnity for the exact
target site. These results further demonstrate the very
high afﬁnity of B for A-rich duplex DNA. Low concen-
trations of B-containing TFOs will therefore need to be
used in potential in vivo applications, reducing the inter-
action with any secondary sites.
Enhanced DNase I cleavage is often observed at the
triplex–duplex boundary (19,24,38). This is only seen on
the duplex purine strand (never on the pyrimidine strand),
but is not observed with all sequences. For example, se-
quences 1 and 14 show no evidence of enhanced DNase I
cleavage. Although both these sequences contain an
adjacent ApC, which is not present in any of the other
sequences, this alone cannot be sufﬁcient to explain the
lack of enhancement as the original target site in
tyr(43-59) is also ﬂanked by ApC. Although we are not
sure of the origin of this difference, which may result from
the A–B transition in the underlying duplex at the triplex–
duplex junction, it has proved very useful in these experi-
ments for delineating the 30-end of the target site. The
presence of multiple enhancements has not been
observed in previous triplex footprints and we interpret
this as indicating that the TFO can bind in different pos-
itions within these targets.
It is also interesting to note that all the cloned sequences
are in the same orientation, in which the purine strand of
the duplex is evident on the footprinting gels (the
T-containing strand is on the same strand as the FokI
site GGATG). There is no reason in principle why the
strands could not be reversed, producing fragments with
aT n tract on the labelled strand. This must be a function
of the way in which FokI cleaves the target triplex. This
enzyme is known to interact with two copies of its target
site before it can cleave the DNA; DNA cleavage only
occurs after two DNA-bound enzymes interact with
each other (40). Since our fragments only contain one
FokI binding site, this interaction must occur between
two separate DNA fragments, either or both of which
might be bound by the TFO. The effect cannot be ex-
plained by suggesting that the enzyme only cleaves one
strand of the underlying duplex, as the remaining strand
would still be ampliﬁed by the PCR. It therefore appears
that under these conditions FokI may still be able to
cleave both duplex strands of the triplex formed at GG
ATG...An, while a similar triplex generated at GGATG
...Tn is refractory to the enzyme. It is also possible that
this strand selectivity might be caused by the effect of low
pH on the FokI enzyme, if the protonation state of the
active site of a FokI monomer on one strand is different to
the protonation state on other monomer.
It should be noted that in all these experiments the
triplex was formed at pH 5.0, before digesting with FokI
at a pH of about 5.6. These non-physiological conditions
were chosen in order to enhance the afﬁnity of this short
(9-mer) oligonucleotide for its target. Stronger binding
could have been achieved by using longer B-containing
oligonucleotides, which would normally be employed
in biological applications, but this would have
increased the number of potential secondary binding
sites. The afﬁnity of this TFO for its exact target site is
pH dependent, as a result of the single third strand
cytosine, with dissociation constants of <100nM at pH
5.0, about 0.3mM at pH 6.0 and 1mM at pH 7.0. The
footprinting experiments show that the afﬁnities for
these secondary sites are typically 0.3–1mM at pH 5.0.
Binding to these sites decreases at higher pH values,
although we assume that the relative discrimination
between target and non-target sites is not pH sensitive.
For in vivo applications of modiﬁed triplex-forming oligo-
nucleotides, the concentrations employed may well be
lower than the afﬁnity for these secondary sites, and so
may not be a problem for such short sequences. However,
longer TFOs may show signiﬁcant interaction with sec-
ondary sites at these concentrations. Other applications
of triplexes, for instance, in detection/diagnostics or
nanostructure formation (41), may well involve conditions
of low pH, as they are not limited by physiological con-
straints. These applications with heavily modiﬁed TFOs
might be affected by annealing to secondary binding sites.
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